RSS Feeds
Insulin Combination Therapy in Type 2 Diabetes Mellitus
- Andreas Fritsche, MD;
- Hans-Ulrich Häring, MD; and
- Matthias Axel Schweitzer, MD
- From Medizinische Universitätsklinik, D-72076 Tübingen, and Aventis Pharma Germany, D-65812 Bad Soden am Taunus, Germany.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
Drs. Hassan, Hassan, and Gupta and Drs. Mikhail and Wali criticize the open-label …
